ADAMTS14, ARHGAP22, and EPDR1 as potential novel targets in acute myeloid leukaemia

OS El-Masry, AM Alamri, F Alzahrani, K Alsamman - Heliyon, 2022 - cell.com
Acute myeloid leukaemia (AML) is a blood cancer with a heterogeneous genomic
landscape. This study aimed to mine bioinformatics data generated by RNA sequencing to …

[HTML][HTML] Whole-transcriptome bioinformatics revealed HTRA3, KRT8, KRT17, and RHEX as novel targets in acute myeloid leukaemia

OS El-Masry, AA Alshwareb, FH Alnasser… - Journal of Taibah …, 2022 - Elsevier
Acute myeloid leukaemia (AML) is characterised by heterogeneous genomic signatures that
vary among different patient groups. Hence, the current study aims to conduct a whole …